课题基金 / 基金详情

HIF dysregulation as a novel genetic model to study retinal neovascular disease.

HIF dysregulation as a novel genetic model to study retinal neovascular disease.
HIF 失调作为研究视网膜新生血管疾病的新型遗传模型。
批准号:
8857468
负责人:
Akrit Singh Sodhi
金额:
$17.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2017-03-31

项目摘要

项目成果

Akrit Singh Sodhi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this proposal is to provide the principal investigator (PI) with the experience and skills necessary to become an independent researcher studying basic mechanisms of retinal neovascular disease. The scientific focus of this proposal is to gain a better understanding of pathological angiogenesis in the eye, a principal cause of irreversible blindness worldwide. Emerging evidence suggests a shared etiology for neovascularization in the eye in which local hypoxia leads to upregulation of the hypoxia inducible factor (HIFs). HIFs are a family of transcription factors which stimulate production of several "hypoxia inducible" genes, including angiogenic growth factors (e.g. vascular endothelial growth factor or VEGF), which, in turn, promote the growth of (leaky) blood vessels. Of interest, significant progress in our understanding of the regulation of HIFs in pathological angiogenesis has come from recent work examining the dysregulation of HIFs in patients with von Hippel-Lindau (VHL) disease. Retinal hemangioblastomas are neovascular tumors that remain the most common clinical manifestation in patients with VHL disease, often manifesting with profuse edema and resulting in profound loss of vision. The VHL protein (pVHL) targets HIFs for degradation. Therefore, loss of pVHL in patients with VHL disease results in dysregulation of HIFs and over expression of hypoxia-inducible genes, mimicking pathological angiogenesis. The underlying hypothesis of this proposal is that VHL retinal hemangioblastomas are a model for pathological angiogenesis and provide an ideal genetic model to examine the role(s) of HIFs and their targets in the breakdown of the inner blood- retinal barrier (iBRB), a poorly understood, but critical early event in retinal neovascular disease. To address this hypothesis, three specific aims are proposed: Aim 1: To examine the necessity for HIFs in the breakdown of the iBRB. Aim 2: To determine if HIF dysregulation is sufficient to promote breakdown of the iBRB. Aim 3: To determine the relative contribution of HIF-dependent growth factors in breakdown of the iBRB. In the course of the proposed research and selected didactic activities, the PI will gain invaluable training experience and mentoring in studying the molecular pathogenesis of retinal neovascular disease. This expertise is deemed essential for the PI who aspires to develop an independent research program studying basic mechanisms of retinal pathological angiogenesis.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Re: Kwon et al.: Aqueous levels of angiopoietin-like 4 and semaphorin 3E correlate with nonperfusion area and macular volume in diabetic retinopathy (Ophthalmology 2015;122:968-75).
回复:Kwon 等人:血管生成素样 4 和脑信号蛋白 3E 的水浓度与糖尿病视网膜病变的非灌注面积和黄斑体积相关(眼科 2015;122:968-75)。
DOI: 10.1016/j.ophtha.2015.05.023
发表时间: 2016
期刊: Ophthalmology
影响因子: 13.7
作者: [Sodhi,Akrit, Montaner,Silvia]
通讯作者: Montaner,Silvia
Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation.
缺氧通过增强的Notch和MAPK激活促进紫veal黑色素瘤的侵袭。
DOI: 10.1371/journal.pone.0105372
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者: [Asnaghi L, Lin MH, Lim KS, Lim KJ, Tripathy A, Wendeborn M, Merbs SL, Handa JT, Sodhi A, Bar EE, Eberhart CG]
通讯作者: Eberhart CG
Angiopoietin-like 4 as an Emerging Therapeutic Target for Diabetic Eye Disease.
血管生成素样 4 作为糖尿病眼病的新兴治疗靶点。
DOI: 10.1001/jamaophthalmol.2015.3723
发表时间: 2015
期刊: JAMA ophthalmology
影响因子: 8.1
作者: [Sodhi,Akrit, Montaner,Silvia]
通讯作者: Montaner,Silvia
Scleral penetration of an unusually aggressive case of a retinal hemangioblastoma.
异常侵袭性视网膜血管母细胞瘤病例的巩膜穿透。
DOI: 10.1016/j.jcjo.2013.01.014
发表时间: 2013
期刊: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
影响因子: --
作者: [Rodrigues,Murilo, Iliff,NicholasT, Eberhart,CharlesG, Montaner,Silvia, Sodhi,Akrit]
通讯作者: Sodhi,Akrit
8
    Molecular Engineering of Novel Therapies to Treat Corneal Neovascularization
    • 批准号:
      10592879
    • 项目类别:
    • 资助金额:
      $24.56万
    • 财政年份:
      2023
    • 负责人:
      Akrit Singh Sodhi
    • 依托单位:
    Divergent Roles for Hypoxia-Inducible Factor-1 and -2 in Ischemic Retinal Disease
    • 批准号:
      10589944
    • 项目类别:
    • 资助金额:
      $53.03万
    • 财政年份:
      2019
    • 负责人:
      Akrit Singh Sodhi
    • 依托单位:
    Divergent Roles for Hypoxia-Inducible Factor-1 and -2 in Ischemic Retinal Disease
    • 批准号:
      10359204
    • 项目类别:
    • 资助金额:
      $51.44万
    • 财政年份:
      2019
    • 负责人:
      Akrit Singh Sodhi
    • 依托单位:
    HIF dysregulation as a novel genetic model to study retinal neovascular disease.
    • 批准号:
      8242691
    • 项目类别:
    • 资助金额:
      $17.96万
    • 财政年份:
      2011
    • 负责人:
      Akrit Singh Sodhi
    • 依托单位:
    海外基金